Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 5, Issue 1, 2013, Pages 59-67

  Torgersen, Terje ^a,b   Gjervan, Bjørn ^a,c   Rasmussen, Kirsten ^a,b   Vaaler, Arne ^a,b   Nordahl, Hans M ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Levanger Hospital   (Norway)

Author keywords

ADHD; Adults; Cannabis; Central stimulants; Relapse; Substance use disorder

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; OPIATE;

ADULT; AGE; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; COHORT ANALYSIS; COMORBIDITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NATURALISTIC INQUIRY; NORWAY; OPIATE ADDICTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOPATHY; RELAPSE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; TREATMENT DURATION;

EID: 84874532063     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-012-0094-2     Document Type: Article

References (48)

1. Amen DG (1997) General adult ADD symptom checklist. In: Clark CG (ed) ADHD throughout the life span. Random Clark, Las Vegas, NV.
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). American Psychiatric Association, Washington.
3. Barkley RA, Murphy KR, Fischer M (2008) Comorbid psychiatric disorders and psychological maladjustments. In: Barkley RA (ed) ADHD in adults: what the science says. The Guildford Press, New York, pp 205-244.
4. Bejerot S, Ryden EM, Arlinde CM (2010) Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study. J Clin Psychiatry 71(12): 1590-1597.
5. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150: 1792-1798.
6. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152: 1652-1658.
7. Clarke S, Heussler H, Kohn MR (2005) Attention deficit disorder: not just for children. Intern Med J 35: 721-725.
8. Cumyn L, French L, Hechtman L (2009) Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry 54: 673-683.
9. Dekel R, Benbenishty R, Amram Y (2004) Therapeutic communities for drug addicts: prediction of long-term outcomes. Addict Behav 29: 1833-1837.
10. DeRogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins symptom checklist (HSCL): a self-report symptom inventory. Behav Sci 19: 1-15.
11. Faraone SV, Glatt SJ (2009) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71(6): 754-763.
12. Fayyad J, de GR, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, de GG, Haro JM, Karam EG, Lara C, Lepine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190: 402-409.
13. Franken IH, Hendriks VM (2001) Screening and diagnosis of anxiety and mood disorders in substance abuse patients. Am J Addict 10: 30-39.
14. Gedaly R, McHugh PP, Johnston TD, Jeon H, Koch A, Clifford TM, Ranjan D (2008) Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation 86: 1090-1095.
15. Halmoy A, Fasmer OB, Gillberg C, Haavik J (2009) Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 13: 175-187.
16. Harty SC, Ivanov I, Newcorn JH, Halperin JM (2011) The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. J Child Adolesc Psychopharmacol 21: 331-339.
17. Hechtman L, Greenfield B (2003) Long-term use of stimulants in children with attention deficit hyperactivity disorder. Pediatr Drug 5(12): 787-794.
18. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 163: 716-723.
19. Kirshenbaum AP, Olsen DM, Bickel WK (2009) A quantitative review of the ubiquitous relapse curve. J Subst Abuse Treat 36: 8-17.
20. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S (2009) Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 23: 733-744.
21. Kollins SH (2008) A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin 24: 1345-1357.
22. Konstenius M, Jayaram-Lindstrom N, Beck O, Franck J (2010) Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend 108: 130-133.
23. Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP (2005) Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 35: 817-827.
24. Kousha M, Shahrivar Z, Alaghband-Rad J (2012) Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor? J Atten Disord 16(4): 325-332.
25. Mannuzza S, Klein RG, Truong NL, Moulton JL III, Roizen ER, Howell KH, Castellanos FX (2008) Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165: 604-609.
26. Mariani JJ, Levin FR (2007) Treatment strategies for co-occuring ADHD and substance use disorders. Am J Addict 16(Suppl 1): 45-54.
27. McCabe SE, Teter CJ, Boyd CJ (2006) Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs 38: 43-56.
28. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S (2005) Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 162: 1621-1627.
29. National Institute for Health and Clinical Excellence (2008) Clinical guidelines CG72. Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. Issued September 2008. Available online at: http://www. nice. org. uk/CG072.
30. Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin DP, Bjornson-Benson WM, Lindgren P, Connett JE (1995) Predictors of initial smoking cessation and relapse through the first 2 years of the lung health Study. J Consult Clin Psychol 63: 60-69.
31. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, Weiss M, Young S (2007) Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21: 10-41.
32. Plebani JG, Kampman KM, Lynch KG (2009) Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes. J Subst Abuse Treat 37: 313-317.
33. Rasmussen K, Levander S (2009) Untreated ADHD in adults: are there sex differences in symptoms, comorbidity, and impairment? J Atten Disord 12: 353-360.
34. Sellman D (2010) The 10 most important things known about addiction. Addiction 105: 6-13.
35. Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, Philipsen A, Rietschel M (2007) Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257: 371-377.
36. Strand PS (2002) Treating antisocial behavior: a context for substance abuse prevention. Clin Psychol Rev 22: 707-728.
37. Thomas VH, Melchert TP, Banken JA (1999) Substance dependence and personality disorders: comorbidity and treatment outcome in an inpatient treatment population. J Stud Alcohol 60: 271-277.
38. Torgersen T, Gjervan B, Rasmussen K (2006) ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry 60: 38-43.
39. Torgersen T, Gjervan B, Rasmussen K (2008) Treatment of adult ADHD: is current knowledge useful to clinicians? Neuropsychiatr Dis Treat 4: 177-186.
40. Torgersen T, Gjervan B, Nordahl HM, Rasmussen K (2012) Predictive factors for more than 3 years of central stimulant treatment in adult ADHD: a retrospective, naturalistic study. J Clin Psychopharmacol 32: 645-652.
41. Upadhyaya HP (2007) Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. J Clin Psychiatry Suppl 11: 23-30.
42. Verstraete AG (2004) Detection times of drugs of abuse in blood, urine and oral fluid. Ther Drug Monit 26(2): 200-205.
43. Wilens TE (2004) Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 27: 283-301.
44. Wilens TE (2009) ADHD with substance use disorders. In: Brown TE (ed) ADHD comorbidities. Handbook for ADHD complications in children and adults. American Psychiatric Publishers, Inc., Arlington, pp 249-264.
45. Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M (2005) The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? J Child Adolesc Psychopharmacol 15: 787-798.
46. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J (2006) Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 45: 408-414.
47. Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, Biederman J (2008) Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 162: 916-921.
48. World Health Organization (1992) The international classification of disease, 10th revision. Geneva.